About GenoPalate
GenoPalate is a company based in Milwaukee (United States) founded in 2016 by Sherry Zhang. GenoPalate has raised $15.66 million across 9 funding rounds from investors including Gener8tor and BrightStar Wisconsin Foundation. GenoPalate operates in a competitive market with competitors including Viome, Invitae, Color, Everlywell and Variant Bio, among others.
- Headquarter Milwaukee, United States
- Founders Sherry Zhang
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.66 M (USD)
in 9 rounds
-
Latest Funding Round
$250 K (USD), Series A
Feb 09, 2026
-
Investors
Gener8tor
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of GenoPalate
Unlock access to complete
Product Management Team
1 people
Software Development Team
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of GenoPalate
GenoPalate has successfully raised a total of $15.66M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $250 thousand completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series A — $250,000
-
First Round
First Round
(01 Jun 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2026 | Amount | Series A - GenoPalate | Valuation |
investors |
|
| Oct, 2024 | Amount | Series A - GenoPalate | Valuation |
investors |
|
| Oct, 2022 | Amount | Series A - GenoPalate | Valuation |
investors |
|
Investors in GenoPalate
GenoPalate has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Gener8tor and BrightStar Wisconsin Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated via a 12-week program with funding support.
|
Founded Year | Domain | Location | |
|
Capital is provided to Wisconsin entrepreneurs for job creation.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenoPalate
Financial Statements - GenoPalate
Genopalate Comparisons
Competitors of GenoPalate
GenoPalate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Invitae, Color, Everlywell and Variant Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| domain | founded_year | HQ Location |
Personalized therapeutics are developed using genomic data for rare diseases.
|
|
| domain | founded_year | HQ Location |
Health management platform is provided for employers and insurers.
|
Frequently Asked Questions about GenoPalate
GenoPalate was founded in 2016 and raised its 1st funding round 1 year after it was founded.
GenoPalate is headquartered in Milwaukee, United States. It is registered at Milwaukee, Wisconsin, United States.
Sherry Zhang is the current CEO of GenoPalate. They have also founded this company.
GenoPalate is a funded company, having raised a total of $15.66M across 9 funding rounds to date. The company's 1st funding round was a Series A of $5.6M, raised on Jun 01, 2017.
GenoPalate was founded in 2016 in Milwaukee, United States, and operates in the personalized nutrition sector. DNA test kits are provided for sample collection, which are analyzed using a proprietary algorithm. Reports with diet and food recommendations are generated from the results. A customized toolkit containing nutritional information and advice is supplied to consumers for ongoing use.
GenoPalate's top competitors include Viome, Variant Bio and Segterra (InsideTracker).
GenoPalate has 2 investors. Key investors include Gener8tor, and BrightStar Wisconsin Foundation.